CClinicalTrials.gg
CompletedNCT05939050Updated Jul 11, 2023

The Long-term Effect on Oral Health Using a Powered Toothbrush in Individuals With Mild Cognitive Impairment

An interventional study of Powered toothbrush in Oral Health and Quality of Life, sponsored by Blekinge Institute of Technology. Completed at 2 sites in Sweden. Open to participants aged 55 Years and older. Per ClinicalTrials.gov, last updated 2023-07-11.

Sponsored by Blekinge Institute of Technology · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 5 years after the study started (first participant enrolled Jun 2018, registered Jun 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
170
Allocation
Not applicable
Ages
55 Years and older
Sex
All
01

Study summary

For this study, 213 individuals with Mild Cognitive Impairment were recruited. The study period ran from June 2018 to October 2021. The procedure involved a combined screening and baseline examination, including oral, medical, cognitive, and quality-of-life examinations. Re-examinations followed this at 6, 12, and 24 months. The examinations were performed at a university research clinic, and all participants received their usual medical and dental care during the study. At baseline, each participant received a powered toothbrush. Participants were carefully instructed on how to operate the powered toothbrush and were asked to brush for at least two minutes in the morning and evening. No restrictions were given against the use of other oral care products. Compliance with the powered toothbrush was followed by a participant survey conducted at each examination.. Facilitating and improving life by introducing a powered toothbrush as part of oral hygiene may benefit individuals with MCI. This study aimed to investigate whether the use of a powered toothbrush could maintain or improve oral health by reducing dental plaque (PI), bleeding on probing (BOP), and periodontal pocket depth (PPD)≥4mm in a group of individuals with MCI for an observation period of 24 months. Furthermore, to study how oral health changes affect QoL aspects.

02

Conditions studied

  • Oral Health
  • Quality of Life

Keywords

  • Mild Cognitive Impairment
  • Oral Health
  • Quality of Life
  • Powered toothbrush
03

In context

Cognitive Dysfunction

3,843 studies on the registry are indexed under Cognitive Dysfunction; 1,100 are open to participants now.

This study's enrollment of 170 is above the median of 65 across 2,808 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Blekinge Institute of Technology is the lead sponsor of 13 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Being 55 years or older
  • Having experienced memory problems in the last six months before inclusion
  • Having a Mini-Mental State Examination score of 20-28
  • Are not receiving any formal care
  • Having at least ten teeth of their own

Exclusion criteria

Exclusion Criteria:

  • Having a terminal illness with less than three years of expected survival
  • Having another known significant cause of disease explaining cognitive impairment
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
170 participants (actual)

Study arms

  • Experimental
    Partisipants

    Device: Powered toothbrush

Interventions

  • DevicePowered toothbrush

    Oral-B Powered toothbrush

06

What researchers measure

Primary outcomes

  1. Change in the amount of dental plaque

    Presence of dental plaque measured on four of the tooth surfaces presented as a percentage

    Time frame: From baseline, to month 6, and to month 12, and to month 24, and to month 36

  2. Change in the amount of gingival bleeding on probing

    Number of bleeding from the gingiva measured on four sides of the teeth presented as a percentage

    Time frame: From baseline, to month 6, and to month 12, and to month 24, and to month 36

  3. Change in the number of periodontal pockets 4 mm or deeper

    The number of periodontal pockets 4 mm or deeper measured on four of the tooth surfaces presented as a percentage

    Time frame: From baseline, to month 6, and to month 12, and to month 24, and to month 36

  4. Change in values for the quality of life instrument QoL-AD

    The value for the quality of life instrument QoL-AD (Quality of Life Alzheimer Disease) is measured on a scale from 0-30, where 30 corresponds to the highest quality of life

    Time frame: From baseline, to month 6, and to month 12, and to month 24, and to month 36

  5. Change in values for the oral health related quality of life instrument OHIP-14

    The value for the oral health-related quality of life instrument OHIP-14 (Oral Health Impact Profile-14) is measured on a scale from 0-56 where 0 corresponds to the highest quality of life

    Time frame: From baseline, to month 6, and to month 12, and to month 24, and to month 36

07

Study locations

2 sites
  • Blekinge Institute of Technology
    Karlskrona, 37179, Sweden
  • Johan Flyborg
    Karlskrona, 37179, Sweden
08

References and documents

Individual participant data

Plan to share: Yes — The trial protocol and the datasets used and analyzed during the current study are available from the corresponding author upon reasonable request.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 11, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05939050
Lead sponsor
Blekinge Institute of Technology
Collaborators
Kristianstad University
Responsible party
Sponsor
First posted
Jul 11, 2023
Start date
Jun 1, 2018
Primary completion
Jan 15, 2023
Completion
Jan 30, 2023
Last update
Jul 11, 2023

Study contacts

Johan Sanmartin-Berglund, Professor
study chair · Blekinge Institute of Technology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion